Peptilogics

Peptilogics is a clinical-stage biotechnology company based in Pittsburgh, PA, founded in 2013. The company focuses on peptide therapeutic discovery, utilizing machine learning and computational platforms to create innovative treatments for serious diseases. With a team of 28 employees and $44.1 million in funding, Peptilogics is committed to advancing its pipeline of anti-infective therapies. The company operates a proprietary computational drug discovery platform that accelerates the design and development of peptides. This platform leverages AI and machine learning to engineer peptides efficiently, addressing challenges associated with traditional methods. Peptilogics is particularly known for its eCAP technology, which improves the stability and efficacy of antimicrobial peptides, targeting serious infections and exploring additional disease areas. Led by CEO Jonathan Steckbeck, Peptilogics employs a recurring revenue model, partnering with clients in the biopharmaceutical sector to develop peptide-based therapeutics. The company is focused on scaling its operations and expanding its therapeutic offerings.

Biotechnology Pittsburgh, United States ~18 employees Private · Series B

Work at Peptilogics in HR or recruiting? Claim this page

Employees
18
-10% in the 3 months to Jun 2025
Total funding
$45.2M
Last round Series B, Dec 2020
12-month attrition
16.4%
H1B sponsor
NA

Headcount trend

Peptilogics went from 23 employees in Jul 2023 to 18 in Jun 2025. Jan to Jun 2025: 0 people joined, 3 left.

Headcount data through Jun 2025

Funding rounds

Total funding$45.2M
Funding rounds6
Investors6
DateRoundMoney raisedNo.Investors
Dec 2020Series B$35.4M2
Feb 2020Funding$2.6M2
Feb 2020Funding–1
Sep 2017Series A$5.5M2
Jan 2016Seed$417K––
Jan 2016Seed$1.3M––

Org structure

Headcount by department

Other14
Operations3
Finance1

Peptilogics FAQ

How many employees does Peptilogics have?

Peptilogics has about 18 employees, down 10% over the 3 months to Jun 2025.

How much funding has Peptilogics raised?

Peptilogics has raised $45.18M in total funding; its latest round was Series B in Dec 2020.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.